The initial contract will last 2 years, for an estimated tender budget of EUR 929 723.00.

Extensions are contemplated for an additional 3 years, for an amount of EUR 1,394,584.50.

The amount for modifications amounts to EUR 185 944.6.

The maximum estimated total amount for the maximum period of 5 years 2 510 252.10 EUR.

The amounts are estimated, depending on their acquisition of the needs of the contracting administration.

A contract will be made for each winner.

Molecular detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis, Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum.

Detection of rotavirus + adenovirus 40/41 antigen in feces.

Detection of Helicobacter pylori antigen in feces.

Molecular diagnosis of bacterial gastroenteritis: Salmonella spp .; Shigella spp./EIEC; Campylobacter spp. (C. jejuni and C. coli); microorganisms

Molecular diagnosis of gastroenteritis by virus: Norovirus, rotavirus, adenovirus, astrovirus and sapovirus.

Molecular diagnosis of parasite gastroenteritis: Giardia lamblia, Cryptosporidium spp. (C. parvum and C. hominis) and Entamoeba histolytica.

Detection by PCR of C. difficile in feces.

Detection of Antigen and Toxin A and B of C. difficile in feces.

Antiserum for the serological identification of enteropathogens (Salmonella spp., Shigella spp .; Yersinia enterocolitica; and E. coli enterohemorrhagic) using a portal agglutination technique.

Detection of Giardia duodenalis and Cryptosporidium spp. in stool

Stool norovirus antigen detection.